Skip to content
OpenCapital
Get started

Merit Medical Systems MMSI Change in fair value of contingent consideration

Change in fair value of contingent consideration at other companies

TFX
TeleflexTFX
-$2.63M-46.6%
LivaNova logo
LivaNovaLIVN
$10.66M+1,056%

Other financials

Income statement

See full
Revenue$381.9M+7.5%
Gross profit$184.8M+7.4%
Operating income$44.2M+7.6%
Net income$41.0M+36.0%
EPS (diluted)$0.68+38.8%

Balance sheet

See full
Cash & equivalents$488.1M+23.4%
Total debt$821.6M+0.5%
Total equity$1.6B+13.9%
Total assets$2.7B+10.2%

Cash flow

See full
Operating cash flow$40.7M+0.3%
CapEx$16.0M-24.0%
Free cash flow$24.7M+26.5%

Valuation

See full
Market cap$4.01B-34.1%

Profitability

See full
Gross margin48.7%+0.9pp
Operating margin12.2%+0.6pp
Net margin9%+0.2pp
FCF margin14.3%+1.3pp

Returns & leverage

See full
Return on equity9.1%0.0pp
Debt / equity0.5×-0.1×
Current ratio5.1×+0.2×

Where this comes from

Reported directly by Merit Medical Systems in its filing.

Tagged under the XBRL concept us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1.

The official record: Merit Medical Systems’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Merit Medical Systems's change in fair value of contingent consideration.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Merit Medical Systems's change in fair value of contingent consideration?
Merit Medical Systems (MMSI) reported change in fair value of contingent consideration of -$179K in Q1 2026.
How has Merit Medical Systems's change in fair value of contingent consideration changed year-over-year?
Merit Medical Systems's change in fair value of contingent consideration decreased by 117.5% year-over-year, from $1.02M to -$179K.
What does change in fair value of contingent consideration mean?
Reflects the non-cash adjustments to the estimated fair value of liabilities owed to sellers of acquired businesses based on future performance milestones. Changes in this value indicate management's updated expectations regarding the success of integration and the achievement of earn-out targets. It serves as a proxy for the perceived risk and performance trajectory of recent acquisitions.